Previous Posts
- FDA Recalls Generic version of drug of Powerful Se...
- FDA Announces Label Change for Certain Immunosuppr...
- Eli Lilly Blood Thinner Approved, despite safety r...
- Veterans Affairs Facility Putting Patients at Risk...
- Mallinckrodt recalls One Lot of Sodium Chromate In...
- Philadelphia Swim Club Accused of Racial Discrimin...
- Class I Recall for Respironics' BiPAP Focus Non-In...
- Smoke Detector Recalled for Possible Failure to Al...
- Government Officials Pushing for Stricter Labeling...
- Nine Companies Penalized for Excessive Lead Paint ...
Click Here to View
Our Other Site
Wednesday, July 15, 2009
Study Says Hormone Therapy Increases Risk of Ovarian Cancer
According to a study published in the Journal of the American Medicine Association, women who use hormone therapy after menopause may be at a higher risk of ovarian cancer, and the risk remains elevated for up to two years after women stop taking estrogen. What’s more, even a relatively short duration of hormone therapy, less than four years, is associated with a 30 to 40 percent higher risk of ovarian cancer in current users, researchers said.
Hormone therapy has been linked to health hazards in the past. Notably, part of a long- term government run study known as the Women’s Health Initiative was stopped early in 2002 because women who took hormones for many years had an increased risk of breast cancer, stroke, heart disease, and blood clots in their lungs and legs. Since then, the use of hormones, once offered to millions of older women to treat menopause symptoms and potentially protect against heart disease, has dropped dramatically. Breast cancer rates have also dropped, most likely because of decline long- term hormone use, experts say.
“Women currently taking hormones seem to reduce their risk of ovarian cancer by quitting hormone use,” says study author Linda Steinrud Morch of Rigshospitalet- Copenhagen University, in Denmark. “The risk warrants consideration when deciding whether to use hormone therapy, particularly if a woman has a special predisposition for ovarian cancer. She should consider not taking hormones.”
For more information see: http://www.cnn.com/2009/HEALTH/07/14/ovarian .cancer.hrt/index.html
Hormone therapy has been linked to health hazards in the past. Notably, part of a long- term government run study known as the Women’s Health Initiative was stopped early in 2002 because women who took hormones for many years had an increased risk of breast cancer, stroke, heart disease, and blood clots in their lungs and legs. Since then, the use of hormones, once offered to millions of older women to treat menopause symptoms and potentially protect against heart disease, has dropped dramatically. Breast cancer rates have also dropped, most likely because of decline long- term hormone use, experts say.
“Women currently taking hormones seem to reduce their risk of ovarian cancer by quitting hormone use,” says study author Linda Steinrud Morch of Rigshospitalet- Copenhagen University, in Denmark. “The risk warrants consideration when deciding whether to use hormone therapy, particularly if a woman has a special predisposition for ovarian cancer. She should consider not taking hormones.”
For more information see: http://www.cnn.com/2009/HEALTH/07/14/ovarian .cancer.hrt/index.html
Labels: blood clot, breast cancer, heart disease, Journal of American Medicine Association, menopause symptoms, ovarian cancer
posted by
Chavon Williams
at
7:56 AM
<< Home